+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Biological Implants Market by Product (Allografts, Autografts, Xenografts), Mode of Administration (Injectable, Surgical), Application - Forecast 2024-2030- Product Image
Global Biological Implants Market by Product (Allografts, Autografts, Xenografts), Mode of Administration (Injectable, Surgical), Application - Forecast 2024-2030- Product Image
Sale

Global Biological Implants Market by Product (Allografts, Autografts, Xenografts), Mode of Administration (Injectable, Surgical), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 184 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5336637
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biological Implants Market size was estimated at USD 33.73 billion in 2023, USD 40.90 billion in 2024, and is expected to grow at a CAGR of 21.36% to reach USD 130.84 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biological Implants Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biological Implants Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biological Implants Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Allografts.com, Alphatec Spine, Inc., Altogen Labs, Auto Tissue Berlin GmbH, Baxter International, Inc., BioPolymer GmbH & Co. KG, Citagenix Inc., Conmed Corporation, CryoLife, Inc., Edward LifeSciences Corporation, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KLS Martin, L.P. by Leibinger family, Medical Device Business Services, Inc., Medtronic PLC, NuVasive, Inc. by Globus Medical Inc, RTI Surgical, Inc., Sanara MedTech, Inc., Stryker Corporation, Surgenex LLC, TissueTech, Inc., and Zimmer Biomet Holdings, Inc.

Market Segmentation & Coverage

This research report categorizes the Biological Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Allografts
    • Autografts
    • Xenografts
  • Mode of Administration
    • Injectable
    • Surgical
  • Application
    • Cardiovascular Implants
    • Orthopedic Implants
    • Soft Tissue Implants
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Biological Implants Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biological Implants Market?
  3. What are the technology trends and regulatory frameworks in the Biological Implants Market?
  4. What is the market share of the leading vendors in the Biological Implants Market?
  5. Which modes and strategic moves are suitable for entering the Biological Implants Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biological Implants Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant advancement in precise implant surgical procedures
5.1.1.2. Increasing aging population coupled with instances of diseases such as orthopedic and spinal disorders
5.1.1.3. Rising awareness of cosmetic implants
5.1.2. Restraints
5.1.2.1. High production cost
5.1.3. Opportunities
5.1.3.1. Technological innovations such as 3D printing and laser technology
5.1.3.2. Advancements in regenerative medicine and tissue engineering
5.1.4. Challenges
5.1.4.1. Scant reimbursement issues
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Biological Implants Market, by Product
6.1. Introduction
6.2. Allografts
6.3. Autografts
6.4. Xenografts
7. Biological Implants Market, by Mode of Administration
7.1. Introduction
7.2. Injectable
7.3. Surgical
8. Biological Implants Market, by Application
8.1. Introduction
8.2. Cardiovascular Implants
8.3. Orthopedic Implants
8.4. Soft Tissue Implants
9. Americas Biological Implants Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biological Implants Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Biological Implants Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Allografts.com
13.1.3. Alphatec Spine, Inc.
13.1.4. Altogen Labs
13.1.5. Auto Tissue Berlin GmbH
13.1.6. Baxter International, Inc.
13.1.7. BioPolymer GmbH & Co. KG
13.1.8. Citagenix Inc.
13.1.9. Conmed Corporation
13.1.10. CryoLife, Inc.
13.1.11. Edward LifeSciences Corporation
13.1.12. Integra LifeSciences Corporation
13.1.13. Johnson & Johnson Services, Inc.
13.1.14. KLS Martin, L.P. by Leibinger family
13.1.15. Medical Device Business Services, Inc.
13.1.16. Medtronic PLC
13.1.17. NuVasive, Inc. by Globus Medical Inc
13.1.18. RTI Surgical, Inc.
13.1.19. Sanara MedTech, Inc.
13.1.20. Stryker Corporation
13.1.21. Surgenex LLC
13.1.22. TissueTech, Inc.
13.1.23. Zimmer Biomet Holdings, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. BIOLOGICAL IMPLANTS MARKET RESEARCH PROCESS
FIGURE 2. BIOLOGICAL IMPLANTS MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOLOGICAL IMPLANTS MARKET DYNAMICS
FIGURE 7. BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. BIOLOGICAL IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. BIOLOGICAL IMPLANTS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BIOLOGICAL IMPLANTS MARKET SIZE, BY AUTOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BIOLOGICAL IMPLANTS MARKET SIZE, BY XENOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 10. BIOLOGICAL IMPLANTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BIOLOGICAL IMPLANTS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BIOLOGICAL IMPLANTS MARKET SIZE, BY SOFT TISSUE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 31. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 112. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 144. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 145. BIOLOGICAL IMPLANTS MARKET LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Allografts.com
  • Alphatec Spine, Inc.
  • Altogen Labs
  • Auto Tissue Berlin GmbH
  • Baxter International, Inc.
  • BioPolymer GmbH & Co. KG
  • Citagenix Inc.
  • Conmed Corporation
  • CryoLife, Inc.
  • Edward LifeSciences Corporation
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • KLS Martin, L.P. by Leibinger family
  • Medical Device Business Services, Inc.
  • Medtronic PLC
  • NuVasive, Inc. by Globus Medical Inc
  • RTI Surgical, Inc.
  • Sanara MedTech, Inc.
  • Stryker Corporation
  • Surgenex LLC
  • TissueTech, Inc.
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 40.9 Billion
Forecasted Market Value ( USD ) by 2030 $ 130.84 Billion
Compound Annual Growth Rate21.3%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Biological Implants Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Biological Implants Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Bio-Implants Market Report by Type of Bio-Implants, Material, Origin, Mode of Administration, End User, and Region 2024-2032 - Product Image

Bio-Implants Market Report by Type of Bio-Implants, Material, Origin, Mode of Administration, End User, and Region 2024-2032

  • Report
  • 142 Pages
  • Global
From
Global Biological Implants Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Biological Implants Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 200 Pages
  • Global
From
Biological Implants Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 - Product Image

Biological Implants Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

  • Report
  • 182 Pages
  • Global
From
Biological Implant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Biological Implant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 113 Pages
  • Global
From

About the Bioimplant Market

Bioimplant is a type of biomaterial used in medical applications. It is a device that is implanted into the body to replace or support a biological structure or function. Bioimplants are typically made from biocompatible materials such as metals, ceramics, polymers, and composites. These materials are designed to be compatible with the body and to provide a safe and effective solution for medical applications. Bioimplants are used in a variety of medical applications, including orthopedic, cardiovascular, dental, and ophthalmic. They are also used in the treatment of cancer, neurological disorders, and other medical conditions. Bioimplants are designed to be durable and to provide long-term performance. The bioimplant market is growing rapidly due to the increasing demand for medical devices and the development of new technologies. The market is expected to continue to grow in the coming years as more medical applications are developed and new materials are developed. Some of the major companies in the bioimplant market include Johnson & Johnson, Zimmer Biomet, Stryker, Medtronic, and Smith & Nephew. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.